{"organizations": [], "uuid": "22fbe0d9dd98a91eac0f715152e27e038d4ff81b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-newlink-genetics-cantor-fitzgerald/brief-newlink-genetics-cantor-fitzgerald-enter-controlled-equity-offering-sales-agreement-idUSFWN1QV0AC", "country": "US", "domain_rank": 408, "title": "BRIEF-NewLink Genetics, Cantor Fitzgerald Enter Controlled Equity Offering Sales Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T12:18:00.000+02:00", "replies_count": 0, "uuid": "22fbe0d9dd98a91eac0f715152e27e038d4ff81b"}, "author": "", "url": "https://www.reuters.com/article/brief-newlink-genetics-cantor-fitzgerald/brief-newlink-genetics-cantor-fitzgerald-enter-controlled-equity-offering-sales-agreement-idUSFWN1QV0AC", "ord_in_thread": 0, "title": "BRIEF-NewLink Genetics, Cantor Fitzgerald Enter Controlled Equity Offering Sales Agreement", "locations": [], "entities": {"persons": [{"name": "cantor fitzgerald", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "brief-newlink genetics", "sentiment": "negative"}, {"name": "cantor fitzgerald & co", "sentiment": "none"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "newlink genetics corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 18 AM / in 14 minutes BRIEF-NewLink Genetics, Cantor Fitzgerald Enter Controlled Equity Offering Sales Agreement Reuters Staff 1 Min Read March 13 (Reuters) - NewLink Genetics Corp: * NEWLINK GENETICS SAYS ON MARCH 12, CO ENTERED CONTROLLED EQUITY OFFERING(SM)SALES AGREEMENT WITH CANTOR FITZGERALD & CO - SEC FILING * NEWLINK GENETICS - UNDER TERMS CO MAY OFFER, SELL THROUGH CANTOR, SHARES OF CO'S COMMON STOCK PAR VALUE $0.01PER SHARE UP TO $60.0 MILLION Source: ( bit.ly/2FJZHq7 ) Further company coverage:", "external_links": [], "published": "2018-03-13T12:18:00.000+02:00", "crawled": "2018-03-13T12:38:42.015+02:00", "highlightTitle": ""}